Diabetes mellitus (DM) is a metabolic disorder characterized by frequent urination, hunger
and high blood sugar level. α-glucosidase inhibitors are considered as a frontline treatment …

Diabetes mellitus is a chronic disease in which the infected cells do not have the ability to
produce sufficient amount of insulin that results in the abnormality of carbohydrates …

Abstract α-Glucosidase inhibition is considered as an effective strategy for the treatment of
diabetes mellitus. Currently, three α-glucosidase inhibitors are being used as drugs; …

Diabetes mellitus (DM) is a metabolic disorder and a significant health problem all over the
world. The current study elucidates the inhibitory potentials of the benzothiazine-pyrazole …

In this work, novel anti‐α‐glucosidase agents, thieno [2, 3‐b] quinoline‐acetamide
derivatives 5 a–m have been designed and synthesized. These compounds were evaluated …

In this article, 26 compounds of substituted quinoline derivatives were synthesized and their
α-glucosidase inhibition activity against the α-glucosidase enzyme was investigated. The …

Diabetes is a leading cause of kidney failure, blindness, heart attacks and lower limb
amputation. Prevalence of diabetes is rising globally. α-glucosidase is validated target for …

An in-silico study was performed to investigate the anti-diabetic activities of 27 Oxadiazoles
derivatives. The anti-diabetic compounds were optimized using Density Functional Theory …

Diabetes mellitus is considered as one of the principal global health urgencies of the twenty
first century. In the present investigation, novel N-substituted 2, 4-thiazolidinedione …

Diabetes mellitus is a metabolic disease caused due to the improper secretion of insulin
which leads to hyperglycaemia. According to the International Diabetes Federation (IDF) …